journal article·2024-10-29Open access

Extracellular Vesicle Mobility in Collagen I Hydrogels Is Influenced by Matrix-Binding Integrins

Nicky W. Tam, Alexander Becker, Agustín Mangiarotti, Amaia Cipitria, Rumiana Dimova

ACS Nano· Volume 18· Issue 43

Abstract

Extracellular vesicles (EVs) are a diverse population of membrane structures produced and released by cells into the extracellular space for the intercellular trafficking of cargo molecules. They are implicated in various biological processes, including angiogenesis, immunomodulation, and cancer cell signaling. While much research has focused on their biogenesis or their effects on recipient cells, less is understood about how EVs are capable of traversing diverse tissue environments and crossing biological barriers. Their interactions with extracellular matrix components are of particular interest, as such interactions govern diffusivity and mobility, providing a potential basis for organotropism. To start to untangle how EV-matrix interactions affect diffusivity, we use high speed epifluorescence microscopy, single particle tracking, and confocal reflectance microscopy to analyze particle mobility and localization in extracellular matrix-mimicking hydrogels composed of collagen I. EVs are compared with synthetic liposomes and extruded plasma membrane vesicles to better understand the importance of membrane composition on these interactions. By treating EVs with trypsin to digest surface proteins, we determine that proteins are primarily responsible for EV immobilization in collagen I hydrogels. We next use a synthetic peptide competitive inhibitor to narrow down the identity of the proteins involved to argynylglycylaspartic acid (RGD) motif-binding integrins, which interact with unincorporated or denatured nonfibrillar collagen. Moreover, the effect of integrin inhibition with RGD peptides has strong implications for the use of RGD-peptide-based drugs to treat certain cancers, as integrin inhibition appears to increase EV mobility, improving their ability to infiltrate tissue-like environments.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Cell Adhesion Molecules Research · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Max Planck Institute of Colloids and Interfaces, Science Park Golm, Potsdam 14476, Germany

McGill University

Group of Bioengineering in Regeneration and Cancer, Biogipuzkoa Health Research Institute

IKERBASQUE, Basque Foundation for Science

Funding

Deutscher Akademischer Austauschdienst · Ministerio de Ciencia e Innovaci??n · Ikerbasque, Basque Foundation for Science · Deutsche Forschungsgemeinschaft

References (100+)

Show source-provided references
1. 10.1007/s00018-017-2595-910.1007/s00018-017-2595-9 ↗
2. 10.1016/j.ccell.2016.10.00910.1016/j.ccell.2016.10.009 ↗
3. 10.1186/s13287-016-0316-110.1186/s13287-016-0316-1 ↗
4. 10.1371/journal.pbio.300036310.1371/journal.pbio.3000363 ↗
5. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
6. 10.3390/biom803009410.3390/biom8030094 ↗
7. 10.3402/jev.v5.3257010.3402/jev.v5.32570 ↗
8. 10.1016/j.tcb.2013.10.00910.1016/j.tcb.2013.10.009 ↗
9. 10.1016/j.celrep.2013.10.05010.1016/j.celrep.2013.10.050 ↗
10. 10.1002/advs.20180131310.1002/advs.201801313 ↗
11. 10.4049/jimmunol.080347710.4049/jimmunol.0803477 ↗
12. 10.1084/jem.183.3.116110.1084/jem.183.3.1161 ↗
13. 10.1371/journal.pone.019110910.1371/journal.pone.0191109 ↗
14. 10.1126/scisignal.200523110.1126/scisignal.2005231 ↗
15. 10.1089/cell.2014.000310.1089/cell.2014.0003 ↗
16. 10.1038/s41389-020-0204-510.1038/s41389-020-0204-5 ↗
17. 10.1042/BST2020071710.1042/BST20200717 ↗
18. 10.1038/ncomms664910.1038/ncomms6649 ↗
19. 10.1016/j.mam.2017.11.01210.1016/j.mam.2017.11.012 ↗
20. 10.1038/ncb316910.1038/ncb3169 ↗
21. 10.1016/j.pharmthera.2018.02.01310.1016/j.pharmthera.2018.02.013 ↗
22. 10.1172/JCI8113010.1172/JCI81130 ↗
23. 10.1038/s41571-018-0036-910.1038/s41571-018-0036-9 ↗
24. 10.1186/s12943-023-01741-x10.1186/s12943-023-01741-x ↗
25. 10.1016/j.ejcb.2023.15137210.1016/j.ejcb.2023.151372 ↗
26. 10.2147/IJN.S2966110.2147/IJN.S29661 ↗
27. 10.3390/biology1002009410.3390/biology10020094 ↗
28. 10.2174/13894501179590657010.2174/138945011795906570 ↗
29. 10.1016/j.addr.2013.12.00810.1016/j.addr.2013.12.008 ↗
30. 10.1021/acs.molpharmaceut.8b0090110.1021/acs.molpharmaceut.8b00901 ↗
31. 10.1007/s12195-016-0458-310.1007/s12195-016-0458-3 ↗
32. 10.3389/fimmu.2015.0005010.3389/fimmu.2015.00050 ↗
33. 10.1007/978-1-61779-289-2_1310.1007/978-1-61779-289-2_13 ↗
34. 10.3402/jev.v4.2631610.3402/jev.v4.26316 ↗
35. 10.1038/s41578-023-00551-310.1038/s41578-023-00551-3 ↗
36. 10.1007/s00281-018-0682-010.1007/s00281-018-0682-0 ↗
37. 10.3390/ijms2404370310.3390/ijms24043703 ↗
38. 10.1016/bs.acc.2018.10.00610.1016/bs.acc.2018.10.006 ↗
39. 10.1002/jex2.13110.1002/jex2.131 ↗
40. 10.1038/nature1575610.1038/nature15756 ↗
41. 10.1016/j.semcancer.2023.05.00310.1016/j.semcancer.2023.05.003 ↗
42. 10.3402/jev.v3.2343010.3402/jev.v3.23430 ↗
43. 10.1038/s41598-017-15717-710.1038/s41598-017-15717-7 ↗
44. 10.1016/j.jsb.2005.06.00210.1016/j.jsb.2005.06.002 ↗
45. 10.1038/s41417-021-00411-810.1038/s41417-021-00411-8 ↗
46. 10.1016/j.ijpharm.2020.11962710.1016/j.ijpharm.2020.119627 ↗
47. 10.1016/j.plipres.2017.03.00110.1016/j.plipres.2017.03.001 ↗
48. 10.1038/nprot.2012.05910.1038/nprot.2012.059 ↗
49. 10.1002/advs.20210210910.1002/advs.202102109 ↗
50. 10.1038/s42003-023-04859-210.1038/s42003-023-04859-2 ↗
51. 10.3892/ijmm.2016.248810.3892/ijmm.2016.2488 ↗
52. 10.1016/j.bbagen.2018.09.00410.1016/j.bbagen.2018.09.004 ↗
53. 10.1074/jbc.M20401920010.1074/jbc.M204019200 ↗
54. 10.1038/s41467-021-24384-210.1038/s41467-021-24384-2 ↗
55. 10.1371/journal.pone.000521910.1371/journal.pone.0005219 ↗
56. 10.1002/ijc.2954210.1002/ijc.29542 ↗
57. 10.1016/S0021-9258(18)49980-210.1016/S0021-9258(18)49980-2 ↗
58. 10.1371/journal.pone.012393010.1371/journal.pone.0123930 ↗
59. 10.1073/pnas.090898710610.1073/pnas.0908987106 ↗
60. 10.1021/acs.accounts.0c0068710.1021/acs.accounts.0c00687 ↗
61. 10.1038/s41467-023-41709-510.1038/s41467-023-41709-5 ↗
62. 10.1016/j.bbamem.2016.07.01710.1016/j.bbamem.2016.07.017 ↗
63. 10.1146/annurev-biophys-062920-06363110.1146/annurev-biophys-062920-063631 ↗
64. 10.1016/j.bbamem.2023.18417610.1016/j.bbamem.2023.184176 ↗
65. 10.1021/la103024f10.1021/la103024f ↗
66. 10.1038/s42003-019-0583-310.1038/s42003-019-0583-3 ↗
67. 10.1016/j.colsurfa.2005.10.01410.1016/j.colsurfa.2005.10.014 ↗
68. 10.1016/S0065-3233(05)70010-310.1016/S0065-3233(05)70010-3 ↗
69. Fratzl P. · 2008 · 110.1007/978-0-387-73906-9 ↗
70. 10.1074/jbc.M40140920010.1074/jbc.M401409200 ↗
71. 10.1098/rsif.2014.081710.1098/rsif.2014.0817 ↗
72. 10.1529/biophysj.105.06199410.1529/biophysj.105.061994 ↗
73. 10.1016/j.bpj.2008.10.06310.1016/j.bpj.2008.10.063 ↗
74. 10.1016/j.bpj.2024.02.00510.1016/j.bpj.2024.02.005 ↗
75. 10.1016/j.bpj.2009.07.00910.1016/j.bpj.2009.07.009 ↗
76. 10.1021/acsnano.5b0387610.1021/acsnano.5b03876 ↗
77. 10.1042/bj091058910.1042/bj0910589 ↗
78. 10.1073/pnas.101618410710.1073/pnas.1016184107 ↗
79. 10.1021/ac301776j10.1021/ac301776j ↗
80. 10.1021/acs.langmuir.0c0249110.1021/acs.langmuir.0c02491 ↗
81. 10.1038/nrm232810.1038/nrm2328 ↗
82. 10.1038/srep3803510.1038/srep38035 ↗
83. 10.1016/S0005-2736(03)00197-410.1016/S0005-2736(03)00197-4 ↗
84. 10.1021/acs.biomac.6b0014610.1021/acs.biomac.6b00146 ↗
85. 10.1016/S0005-2736(97)00027-810.1016/S0005-2736(97)00027-8 ↗
86. Maneewongvatana, S.; Mount, D. M. It’s Okay to Be Skinny, If Your Friends Are Fat. Cent. Geom. Comput. 4th Annu. Work. Comput. Geom., 1999; Vol. 2, pp 1–8.
87. 10.1038/sj.bjc.660014110.1038/sj.bjc.6600141 ↗
88. 10.1016/j.bmcl.2020.12703910.1016/j.bmcl.2020.127039 ↗
89. 10.3892/ijo.2012.170810.3892/ijo.2012.1708 ↗
90. 10.1038/srep3980510.1038/srep39805 ↗
91. 10.1083/jcb.20070302110.1083/jcb.200703021 ↗
92. 10.1007/s00441-009-0834-610.1007/s00441-009-0834-6 ↗
93. 10.1016/0006-291X(92)91834-D10.1016/0006-291X(92)91834-D ↗
94. 10.1016/j.biomaterials.2009.12.05110.1016/j.biomaterials.2009.12.051 ↗
95. 10.1016/S0006-3495(02)73933-710.1016/S0006-3495(02)73933-7 ↗
96. 10.1016/S0092-8674(00)80622-410.1016/S0092-8674(00)80622-4 ↗
97. 10.1074/jbc.275.1.3510.1074/jbc.275.1.35 ↗
98. 10.1073/pnas.87.17.665910.1073/pnas.87.17.6659 ↗
99. 10.1088/1361-6501/ac04df10.1088/1361-6501/ac04df ↗
100. 10.1038/nprot.2012.00910.1038/nprot.2012.009 ↗